Theaflavin Induces Apoptosis of A375 Human Melanoma Cells and Inhibits Tumor Growth in Xenograft Zebrafishes Through P53- and JNK-Related Mechanism

Lei Zhang,Bo Yan,Shijie Meng,Li Zhou,Yiqiao Xu,Wenxi Du,Letian Shan
DOI: https://doi.org/10.3389/fphar.2020.01317
IF: 5.6
2020-08-31
Frontiers in Pharmacology
Abstract:Theaflavin (TF) is a major active pigment and polyphenol of tea, possessing anti-cancer activities. However, little is known about its activity and mechanism on melanoma cells. To fill this gap, we conducted <i>in vitro</i> experiments (cell viability assay, morphology observation, DAPI staining, and flow cytometry) and <i>in vivo</i> experiment by using a xenograft model of larval zebrafishes. Real-time PCR (qPCR) and Western blot (WB) analyses were conducted to explore the mechanism of TF. The <i>in vitro</i> data showed that TF exerted significant anti-proliferative and pro-apoptotic effects on A375 cells in a concentration-dependent manner. <i>In vivo</i>, TF significantly inhibited A375 tumor growth in larval zebrafishes at 0.67 and 2.0 μg/ml (1.3 to 3.9 μM). qPCR and WB data showed that TF significantly activated the P53 pathway-related proteins (ATM, CHK1/2, P53, and CASP8/3) and the JNK pathway-related proteins (ASK1, JNK, and C-JUN) through phosphorylation and cleavage, followed by activation of pro-apoptotic molecules (PARP, <i>BAX</i>, <i>BIM</i>, <i>PUMA</i>, and <i>P53</i>). In sum, TF possessed cytotoxic pro-apoptotic and tumor-inhibitory effects on A375 cells through activations of P53 and JNK pathways. This is the first report on TF regarding its effects and mechanism on A375 cells, making it a promising candidate of natural products for clinical treatment of melanoma.
pharmacology & pharmacy
What problem does this paper attempt to address?